Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Read More…
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Phone314-725-4477
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$60.12 billion
Profitability
Miscellaneous
Employees47,300
Next Earnings Date2/4/2020 (Estimated)
OptionableOptionable
Centene (NYSE:CNC) Frequently Asked Questions
What is Centene's stock symbol?
Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
When did Centene's stock split? How did Centene's stock split work?
Centene's stock split on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were payable to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.
How were Centene's earnings last quarter?
Centene Corp (NYSE:CNC) issued its earnings results on Tuesday, October, 22nd. The company reported $0.96 EPS for the quarter, beating the Zacks' consensus estimate of $0.95 by $0.01. The business earned $18.98 billion during the quarter, compared to the consensus estimate of $18.39 billion. Centene had a net margin of 1.87% and a return on equity of 15.54%. The business's revenue was up 17.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.79 EPS. View Centene's Earnings History.
When is Centene's next earnings date?
What guidance has Centene issued on next quarter's earnings?
Centene issued an update on its FY19 earnings guidance on Tuesday, October, 22nd. The company provided earnings per share (EPS) guidance of $4.29-$4.49 for the period, compared to the Thomson Reuters consensus estimate of $4.41. The company issued revenue guidance of $73.6-$74.2 billion, compared to the consensus revenue estimate of $73.81 billion.
What price target have analysts set for CNC?
12 analysts have issued 12-month target prices for Centene's shares. Their forecasts range from $57.00 to $83.00. On average, they anticipate Centene's share price to reach $72.05 in the next year. This suggests a possible upside of 31.8% from the stock's current price. View Analyst Price Targets for Centene.
What is the consensus analysts' recommendation for Centene?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.
Has Centene been receiving favorable news coverage?
News articles about CNC stock have been trending somewhat negative this week, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Centene earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Centene.
Are investors shorting Centene?
Centene saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 43,160,000 shares, an increase of 5.8% from the September 30th total of 40,810,000 shares. Based on an average trading volume of 4,990,000 shares, the short-interest ratio is currently 8.6 days. Currently, 10.8% of the shares of the stock are sold short. View Centene's Current Options Chain.
Who are some of Centene's key competitors?
What other stocks do shareholders of Centene own?
Who are Centene's key executives?
Centene's management team includes the folowing people:
- Mr. Michael Frederic Neidorff, Chairman, Pres & CEO (Age 76)
- Mr. Jeffrey Alan Schwaneke C.P.A., CPA, Exec. VP, CFO & Treasurer (Age 43)
- Ms. Brandy Lynn Burkhalter, Exec. VP of Operations (Age 46)
- Mr. Mark J. Brooks, Exec. VP & Chief Information Officer (Age 49)
- Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 43)
Who are Centene's major shareholders?
Centene's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.42%), TimesSquare Capital Management LLC (0.37%), Carillon Tower Advisers Inc. (0.30%), Vantage Investment Partners LLC (0.27%), Eagle Asset Management Inc. (0.27%) and Alberta Investment Management Corp (0.22%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Jessica L Blume, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.
Which institutional investors are selling Centene stock?
CNC stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Scout Investments Inc., Carillon Tower Advisers Inc., TimesSquare Capital Management LLC, Russell Investments Group Ltd., California Public Employees Retirement System, Strs Ohio and Rhenman & Partners Asset Management AB. Company insiders that have sold Centene company stock in the last year include Christopher D Bowers, Jeffrey A Schwaneke, Mark J Brooks and Robert K Ditmore. View Insider Buying and Selling for Centene.
Which institutional investors are buying Centene stock?
CNC stock was acquired by a variety of institutional investors in the last quarter, including Vantage Investment Partners LLC, Cambiar Investors LLC, Mackay Shields LLC, Retirement Systems of Alabama, Coronation Fund Managers Ltd., Alberta Investment Management Corp, Sumitomo Mitsui Trust Holdings Inc. and First Trust Advisors LP. Company insiders that have bought Centene stock in the last two years include Jessica L Blume and Stephen Wallace. View Insider Buying and Selling for Centene.
How do I buy shares of Centene?
Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Centene's stock price today?
One share of CNC stock can currently be purchased for approximately $54.65.
How big of a company is Centene?
Centene has a market capitalization of $22.61 billion and generates $60.12 billion in revenue each year. The company earns $900 million in net income (profit) each year or $3.54 on an earnings per share basis. Centene employs 47,300 workers across the globe.View Additional Information About Centene.
What is Centene's official website?
How can I contact Centene?
Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]
MarketBeat Community Rating for Centene (NYSE CNC)
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
